Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

AEON

AEON Biopharma (AEON)

AEON Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:AEON
日付受信時刻ニュースソース見出しコード企業名
2025/07/1001 : 33Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:AEONAEON Biopharma Inc
2025/06/1705 : 02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AEONAEON Biopharma Inc
2025/06/1405 : 05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/06/1205 : 06Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]AMEX:AEONAEON Biopharma Inc
2025/06/1205 : 05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]AMEX:AEONAEON Biopharma Inc
2025/06/1119 : 04Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsAMEX:AEONAEON Biopharma Inc
2025/05/3101 : 10Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AEONAEON Biopharma Inc
2025/05/1505 : 28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AEONAEON Biopharma Inc
2025/05/1505 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AEONAEON Biopharma Inc
2025/05/1505 : 09Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/05/0205 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
2025/05/0205 : 50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
2025/04/3005 : 10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:AEONAEON Biopharma Inc
2025/04/3005 : 06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AEONAEON Biopharma Inc
2025/04/2605 : 06Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/04/2205 : 11Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/04/0905 : 02Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/03/2805 : 06Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/03/2505 : 07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:AEONAEON Biopharma Inc
2025/03/2505 : 06Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/03/1021 : 45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AEONAEON Biopharma Inc
2025/03/1019 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/03/0403 : 51Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AEONAEON Biopharma Inc
2025/02/2504 : 01Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/02/1507 : 09Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:AEONAEON Biopharma Inc
2025/02/0806 : 07Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
2025/01/2406 : 45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AEONAEON Biopharma Inc
2025/01/1406 : 14Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AEONAEON Biopharma Inc
2025/01/0720 : 04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AEONAEON Biopharma Inc
2025/01/0623 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
 Showing the most relevant articles for your search:AMEX:AEON